Clinical Trials Browser

Has announcements × Myelodysplastic Syndromes × treosulfan × Clear all

NCT00822393 2020-07-30

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Phase 3 Completed

570 enrolled 1 FDA

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute